This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 revenue up 23%, PAT down 31%, auditor gives qualified review
PLATIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated results for the quarter ended 30 Sep 2026: revenue from operations was Rs 1,212.66 million versus Rs 983.78 million a year earlier, up 23.3%, while profit after tax fell 30.8% to Rs 75.98 million from Rs 109.83 million. The auditor issued a qualified conclusion on the Rs 98.19 million insurance claim receivable after the July 2025 fire at a subsidiary's Palghar plant.
Qualified review on the insurance receivable and lower quarterly profit may weigh on sentiment, though revenue growth and positive operating cash flow support the outlook.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹121.3 Cr | ₹98.38 Cr | +23.3% |
| Operating profit | ₹7.74 Cr | ₹11.21 Cr | −30.9% |
| Profit after tax | ₹7.60 Cr | ₹10.98 Cr | −30.8% |
| EBITDA margin | 8.9% | 13.3% | −4.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.